Skip to main content
David Robbins, MD, Gastroenterology, New York, NY

David Herbert Robbins MD MSc, FASGE, AGAF, FACG

Advanced Endoscopic Interventional


Program Director www.davidrobbinsmd.com

Join to View Full Profile
  • 100 E 77th StSecond floorNew York, NY 10075

  • Phone+1 212-434-3427

  • Fax+1 212-434-6275

Dr. Robbins is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2001 - 2005
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2001
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1999

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2001 - 2028
  • SC State Medical License
    SC State Medical License 2003 - 2004
  • PA State Medical License
    PA State Medical License 2000 - 2001
  • Gastroenterology
    American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2016-2017
  • CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2016-2017
  • New York Magazine: Top Doctors Castle Connolly, 2014

Publications & Presentations

PubMed

Press Mentions

  • Two More Heartburn Meds Recalled Due to Possible Carcinogen
    Two More Heartburn Meds Recalled Due to Possible CarcinogenJanuary 10th, 2020
  • CVS and Walgreens Stop Selling Zantac After Cancer-Causing Chemical Detected
    CVS and Walgreens Stop Selling Zantac After Cancer-Causing Chemical DetectedOctober 1st, 2019
  • Medicolegal Issues Hinder Adoption of Resect–Discard for Polyps
    Medicolegal Issues Hinder Adoption of Resect–Discard for PolypsMarch 25th, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: